Once-a-day Administration of Everolimus, Cyclosporine, and Steroid After Renal Transplantation: A Review of the Rationale

G. Corbetta, C. Ponticelli

Research output: Contribution to journalArticlepeer-review

Abstract

The Evidence study (EVerolImus once-a-Day rEgimen with Neoral® versus Corticosteroid Elimination) sought to compare once-a-day administration with steroid withdrawal versus twice-daily administration among de novo kidney transplant recipients treated with everolimus, cyclosporine, and steroids. This article describes the study design and rationale of once-daily administration and steroid withdrawal among recipients of de novo kidney transplants treated with everolimus and cyclosporine.

Original languageEnglish
Pages (from-to)1303-1307
Number of pages5
JournalTransplantation Proceedings
Volume42
Issue number4
DOIs
Publication statusPublished - May 2010

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Fingerprint

Dive into the research topics of 'Once-a-day Administration of Everolimus, Cyclosporine, and Steroid After Renal Transplantation: A Review of the Rationale'. Together they form a unique fingerprint.

Cite this